Skip to main content
. 2022 Mar 8;12:3717. doi: 10.1038/s41598-022-07628-z

Table 4.

Comparison results of miRDriver with five other methods in ovarian cancer.

Method Input miRNAs Input genes Computed miRNAs Selected genes Eligible miRNAsa Overlapping eligible miRNAsb Method's computed miRNAs in overlap miRDriver's computed miRNAs in the overlap
miRDriver 198 2114 147 354 27 NA NA NA
ARACNe 198 2114 196 791 59 27 1 24
ProMise 198 2114 57 1938 34 22 0 17
hiddenICP 198 2114 198 2100 47 21 0 16
idaFast 50 1500 50 1194 32 22 0 17
jointIDA 50 1500 50 1294 32 22 0 17

aEligible miRNAs had at least one known target in the ground truth data; bOverlapping eligible miRNAs were with respect to miRDriver. For miRDriver, the number of significant miRNAs in every overlap with other methods was much higher. NA means not applicable.